Ibercaja

18 June, 2025

The IIS Aragón and the Ibercaja Foundation have signed an agreement to promote the innovative oncology research project "Sara."

This research, led by the Molecular Oncology Group at the IIS Aragón, aims to improve the efficacy of chemotherapy while significantly reducing its adverse effects. The signing of this agreement reinforces the commitment of both institutions to the advancement of cancer research in Aragon.
23 May 2025

27rd Congress of the Spanish Society of Neurosurgery: free admission on May XNUMXth

Zaragoza will host the Congress of the Spanish Society of Neurosurgery (SENEC), which will offer a public event for the first time on May 27th. Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, will explore cutting-edge topics such as epigenetics and its applications in brain surgery, among others.
15 May 2025

23rd Congress of the Spanish Society of Neurosurgery: open day to the public

Zaragoza will host the Congress of the Spanish Society of Neurosurgery (SENEC), which will offer a public event for the first time on May 27th. Alberto J. Schuhmacher, head of the Molecular Oncology Group at the IIS Aragón, will explore cutting-edge topics such as epigenetics and its applications in brain surgery, among others.